Susceptibility of clinical isolates of Bacteroides fragilis group strains to cefoxitin, cefoperazone and ticarcillin/clavulanate

Authors

  • Arnaldo Aires PEIXOTO JÚNIOR Universidade Federal do Ceará; Departamento de Patologia e Medicina Legal
  • Márcia Maria de Negreiros P. ROCHA Universidade Federal do Ceará; Departamento de Patologia e Medicina Legal
  • José Luciano Bezerra MOREIRA Universidade Federal do Ceará; Departamento de Patologia e Medicina Legal
  • Cibele Barreto Mano de CARVALHO Universidade Federal do Ceará; Departamento de Patologia e Medicina Legal

Keywords:

Bacteroides fragilis gr, beta-lac, Antimicrobial resista, Anaerobic bacte

Abstract

A total of 40 strains of the B. fragilis group was isolated from clinical specimens in two hospital centers in Fortaleza from 1993 to 1997. The most frequently isolated species was Bacteroides fragilis (19 strains) and most isolates came from intra-abdominal and wound infections. The susceptibility profile was traced for cefoxitin, cefoperazone and ticarcillin-clavulanate by using the agar dilution reference method. All isolates were susceptible to ticarcillin-clavulanate (128/2mug/ml). Resistance rates of 15 and 70% were detected to cefoxitin (64mug/ml) and cefoperazone (64mug/ml), respectively. Such regional results permit a better orientation in choosing this group of antibiotics for prophylaxis and therapy especially in relation to cefoxitin, which is frequently used in the hospital centers studied.

Downloads

Download data is not yet available.

Downloads

Published

2000-06-01

Issue

Section

Therapeutic Trial

How to Cite

PEIXOTO JÚNIOR, A. A., ROCHA, M. M. de N. P., MOREIRA, J. L. B., & CARVALHO, C. B. M. de. (2000). Susceptibility of clinical isolates of Bacteroides fragilis group strains to cefoxitin, cefoperazone and ticarcillin/clavulanate . Revista Do Instituto De Medicina Tropical De São Paulo, 42(3), 137-139. https://www.revistas.usp.br/rimtsp/article/view/30424